PVH
28
-2
MPC
39
3
USB
66
-2
ADI
76
3
EXC
51
-3
PEG
46
-4
WYNN
45
-3
OMC
64
-2
GOOGL
50
2
MTB
73
-2
NOV
53
-2
PEP
29
-3
TXN
50
-2
XYL
33
-2
CPB
35
-4
RCL
66
-3
CMA
65
-6
ECL
59
-3
WY
54
-2
SRE
49
2
PVH
28
-2
MPC
39
3
USB
66
-2
ADI
76
3
EXC
51
-3
PEG
46
-4
WYNN
45
-3
OMC
64
-2
GOOGL
50
2
MTB
73
-2
NOV
53
-2
PEP
29
-3
TXN
50
-2
XYL
33
-2
CPB
35
-4
RCL
66
-3
CMA
65
-6
ECL
59
-3
WY
54
-2
SRE
49
2
Financhill
Back

The Bancorp, Inc. (Delaware) Vs. Structure Therapeutics, Inc. Industry Stock Comparison

Buy
69

TBBK
The Bancorp, Inc. (Delaware)

Last Price:
$70.49
Seasonality Move:
2.13%
Buy
63

GPCR
Structure Therapeutics, Inc.

Last Price:
$71.39
Seasonality Move:
-34.19%
Buy
69
The Bancorp, Inc. (Delaware) (TBBK) is a Buy

Is The Bancorp, Inc. (Delaware) a Buy, Sell or Hold?

  • The current The Bancorp, Inc. (Delaware) [TBBK] share price is $70.51. The Score for TBBK is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
  • TBBK is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
63
Structure Therapeutics, Inc. (GPCR) is a Buy

Is Structure Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Structure Therapeutics, Inc. [GPCR] share price is $71.29. The Score for GPCR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • GPCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

TBBK Stock Price Chart

What is The Bancorp, Inc. (Delaware)'s stock price today?

  • The The Bancorp, Inc. (Delaware) share price today is $70.51
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TBBK is experiencing slight selling pressure.

GPCR Stock Price Chart

What is Structure Therapeutics, Inc.'s stock price today?

  • The Structure Therapeutics, Inc. share price today is $71.29
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing buying pressure, which is a positive indicator for future bullish movement.

TBBK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 17.18 Buy
Relative Strength Index (14 RSI): 63.93 Buy
Chaikin Money Flow: -221626 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (62.63 - 69.07) Buy
Bollinger Bands (100): (64.35 - 76.69) Sell

GPCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.5 Buy
Relative Strength Index (14 RSI): 72.85 Buy
Chaikin Money Flow: 1903413 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.41 - 65.27) Buy
Bollinger Bands (100): (17 - 45.24) Buy

TBBK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 68.86 Buy
20-day SMA: 67.12 Buy
50-day SMA: 67.78 Buy
200-day SMA: 62.33 Buy
8-day EMA: 49.75 Buy
20-day EMA: 27.3 Buy
50-day EMA: 12.55 Buy
200-day EMA: 3.37 Buy

GPCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 64.43 Buy
20-day SMA: 52.92 Buy
50-day SMA: 40.28 Buy
200-day SMA: 26.09 Buy
8-day EMA: 64 Buy
20-day EMA: 55.88 Buy
50-day EMA: 44.22 Buy
200-day EMA: 31.26 Buy

The Bancorp, Inc. (Delaware) Earnings Growth & TBBK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.79 per share, and an increase next year of $1.36 per share.

Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.10 per share.

The Bancorp, Inc. (Delaware) Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Structure Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):